The characteristics of patient groups were used to prove the method’s applicability. by Ewa Paszkowska (21246702)

Subjects:

The observed MRM reactions. by Ewa Paszkowska (21246702)

Subjects:

Differences in health-related quality of life indexes after disease onset between groups. by Ji Woong Chang (1829314)

Subjects:

Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

Subjects:

Solvents for homogenization and extraction selection. by Ewa Paszkowska (21246702)

Subjects:

Chromatograms presented the specificity of the proposed method. by Ewa Paszkowska (21246702)

Subjects:

Demographic characteristics of the participants. by Ji Woong Chang (1829314)

Subjects:

The mevalonate pathway (cholesterol biosynthesis): the place of action of statins, and their main effects. by Ewa Paszkowska (21246702)

Subjects:

The RSD results were obtained for different proportions of the extraction solvent/tissue (each proportion was prepared in triplicate repetition, n = 3). by Ewa Paszkowska (21246702)

Subjects:

Data file. by Ji Woong Chang (1829314)

Subjects:

The influence of the controlled pH conditions at the sample preparation step on the obtained signals (panel A: extraction using a mixture of MeOH and EtOH; panel B: extraction usin... by Ewa Paszkowska (21246702)

Subjects:

Baseline characteristics. by A. H. Ayesha Lavell (16734002)

“…Mental health significantly declined during the COVID-19 pandemic, after which mental health symptoms returned to baseline as the burden of COVID-19 patients decreased and public measures were lifted. …”

De-identified participant survey data. by A. H. Ayesha Lavell (16734002)

“…Mental health significantly declined during the COVID-19 pandemic, after which mental health symptoms returned to baseline as the burden of COVID-19 patients decreased and public measures were lifted. …”

The enzyme activity of GCN2 in <i>H. armigera.</i> by Caihong Zhang (1633294)

Effects of GCN2 inhibitor GCN2iB on larval mortality of Cry1Ac-treated <i>H. armigera.</i> by Caihong Zhang (1633294)

Flexural strengths of alkali-activated composites with different SDW levels when cured for 28, 60, and 90 days. by Liang Li (46069)

Compressive strengths of alkali-activated composites with different SDW levels when cured for 28, 60, and 90 days. by Liang Li (46069)

PIF4 protein level regulates <i>PIF4</i> promoter activity in a temperature-dependent manner. by Sreya Das (20531295)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Estimates of average yearly citations of publications by scholars accused of scientific misconduct by retraction status and time. by Giulia Maimone (20833354)

Subjects: